V. Y. Dudkin et al. / Bioorg. Med. Chem. Lett. 22 (2012) 2613–2619
2619
10. Bilodeau, M. T.; Balitza, A. E.; Koester, T. J.; Manley, P. J.; Rodman, L. D.; Buser-
Doepner, C.; Coll, K. E.; Fernandes, C.; Gibbs, J. B.; Heimbrook, D. C.; Huckle, W.
R.; Kohl, N.; Lynch, J. J.; Mao, X.; McFall, R. C.; McLoughlin, D.; Miller-Stein, C.
M.; Rickert, K. W.; Sepp-Lorenzino, L.; Shipman, J. M.; Subramanian, R.;
Thomas, K. A.; Wong, B. K.; Yu, S.; Hartman, G. D. J. Med. Chem. 2004, 47, 6363.
11. Bilodeau, M. T.; Rodman, L. D.; McGaughey, G. B.; Coll, K. E.; Koester, T. J.;
Hoffman, W. F.; Hungate, R. W.; Kendall, R. L.; McFall, R. C.; Rickert, K. W.;
Rutledge, R. Z.; Thomas, K. A. Bioorg. Med. Chem. Lett. 2004, 14, 2941.
12. Dudkin, V. Y.; Rickert, K.; Kreatsoulas, C.; Wang, C.; Arrington, K. L.; Fraley, M.
E.; Hartman, G. D.; Yan, Y.; Ikuta, M.; Stirdivant, S. M.; Drakas, R. A.; Walsh, E.
S.; Hamilton, K.; Buser, C. A.; Lobell, R. B.; Sepp-Lorenzino, L. Bioorg. Med. Chem.
Lett., (2012), doi: 10.1016/j.bmcl.2012.01.110.
13. NCI-H1299 lung carcinoma cells were arrested with 16 h treatment of
camptothecin, and then treated with Chek1 inhibitors for additional 8 h.
Escape from arrest and progression into mitosis was measured by quantifying
the mitosis-specific phosphorylation of nucleolin using an antibody-coated,
bead-based assay. For assay details, see Fraley, M. E. et al. Bioorg. Med. Chem.
Lett. 2006, 16, 1775, Ref.16. The values of EC50 were measured with 10-point,
half-log dilution series and are reported as an average of tetraplicate
determinations.
Lobell, R. B.; Sepp-Lorenzino, L.; Yan, Y. W.; Ikuta, M.; Munshi, S. K.; Kuo, L. C.;
Kreatsoulas, C. Bioorg. Med. Chem. Lett. 2006, 16, 6049.
15. Note that Chek1 inhibitory activity in the enzyme assay is measured at Km for
ATP (0.1 mM). In the cellular assays, the ATP concentration is 2.0 mM resulting
in an inherent 10-fold shift in potency between the enzyme and cellular assays.
16. PSA was calculated by the method of Clark, D. E. J. Pharm. Sci. 1999, 88, 807.
17. Garbaccio, R. M.; Huang, S.; Tasber, E. S.; Fraley, M. E.; Yan, Y.; Munshi, S.; Ikuta,
M.; Kuo, L.; Kreatsoulas, C.; Stirdivant, S.; Drakas, B.; Rickert, K.; Walsh, E. S.;
Hamilton, K. A.; Buser, C. A.; Hardwick, J.; Mao, X.; Beck, S. C.; Abrams, M. T.;
Tao, W.; Lobell, R.; Sepp-Lorenzino, L.; Hartman, G. D. Bioorg. Med. Chem. Lett
2007, 17, 6280.
18. Huang, S.; Garbaccio, R. M.; Fraley, M. E.; Steen, J.; Kreatsoulas, C.; Hartman, G.;
Stirdivant, S.; Drakas, B.; Rickert, K.; Walsh, E.; Hamilton, K.; Buser, C. A.;
Hardwick, J.; Mao, X.; Abrams, M.; Beck, S.; Tao, W.; Lobell, R.; Sepp-Lorenzino,
L.; Yan, Y.; Ikuta, M.; Murphy, J. Z.; Sardana, V.; Munshi, S.; Kuo, L.; Reilly, M.;
Mahan, E. Bioorg. Med. Chem. Lett. 2006, 16, 5907.
19. Brnardic, E. J.; Garbaccio, R. M.; Fraley, M. E.; Tasber, E. S.; Steen, J. T.; Arrington,
K. L.; Dudkin, V. Y.; Hartman, G. D.; Stirdivant, S. M.; Drakas, B. A.; Rickert, K.;
Walsh, E. S.; Hamilton, K.; Buser, C. A.; Hardwick, J.; Tao, W.; Beck, S. C.; Mao,
X.; Lobell, R. B.; Sepp-Lorenzino, L.; Yan, Y.; Ikuta, M.; Munshi, S. K.; Kuo, L. C.;
Kreatsoulas, C. Bioorg Med Chem Lett 2007.
14. Fraley, M. E.; Steen, J. T.; Brnardic, E. J.; Arrington, K. L.; Spencer, K. L.; Hanney,
B. A.; Kim, Y.; Hartman, G. D.; Stirdivant, S. M.; Drakas, B. A.; Rickert, K.; Walsh,
E. S.; Hamilton, K.; Buser, C. A.; Hardwick, J.; Tao, W. K.; Beck, S. C.; Mao, X. Z.;
20. For full experimental details, see WO2006135604.